| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | cell body | PCSK2 AKAP9 MAP1A MTOR VPS13A LRP1 GRIK1 STK39 TANC1 DYNC1H1 PINK1 | 1.25e-04 | 929 | 65 | 11 | GO:0044297 |
| GeneOntologyCellularComponent | dendritic branch | 1.98e-04 | 7 | 65 | 2 | GO:0044307 | |
| GeneOntologyCellularComponent | clathrin complex | 3.38e-04 | 9 | 65 | 2 | GO:0071439 | |
| GeneOntologyCellularComponent | postsynaptic endocytic zone | 5.14e-04 | 11 | 65 | 2 | GO:0098843 | |
| Domain | CLH | 3.14e-05 | 3 | 61 | 2 | SM00299 | |
| Domain | - | 8.48e-05 | 222 | 61 | 6 | 1.25.10.10 | |
| Domain | Ribosomal_S10 | 1.04e-04 | 5 | 61 | 2 | IPR001848 | |
| Domain | ARM-type_fold | 1.15e-04 | 339 | 61 | 7 | IPR016024 | |
| Domain | Xpo1 | 1.56e-04 | 6 | 61 | 2 | PF08389 | |
| Domain | Exportin-1/Importin-b-like | 1.56e-04 | 6 | 61 | 2 | IPR013598 | |
| Domain | WD40_repeat_CS | 1.96e-04 | 164 | 61 | 5 | IPR019775 | |
| Domain | Clathrin | 2.18e-04 | 7 | 61 | 2 | PF00637 | |
| Domain | CHCR | 2.18e-04 | 7 | 61 | 2 | PS50236 | |
| Domain | ARM-like | 2.46e-04 | 270 | 61 | 6 | IPR011989 | |
| Domain | Clathrin_H-chain/VPS_repeat | 2.90e-04 | 8 | 61 | 2 | IPR000547 | |
| Domain | WD40_repeat_dom | 4.10e-04 | 297 | 61 | 6 | IPR017986 | |
| Domain | - | 7.47e-04 | 333 | 61 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 7.71e-04 | 335 | 61 | 6 | IPR015943 | |
| Domain | IBN_N | 1.22e-03 | 16 | 61 | 2 | SM00913 | |
| Domain | Importin-beta_N | 1.38e-03 | 17 | 61 | 2 | IPR001494 | |
| Domain | HEAT_REPEAT | 1.55e-03 | 70 | 61 | 3 | PS50077 | |
| Domain | WD40 | 1.56e-03 | 259 | 61 | 5 | PF00400 | |
| Domain | WD40 | 1.81e-03 | 268 | 61 | 5 | SM00320 | |
| Domain | Apc4_WD40_dom | 1.92e-03 | 20 | 61 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 1.92e-03 | 20 | 61 | 2 | PF12894 | |
| Domain | WD40_repeat | 1.93e-03 | 272 | 61 | 5 | IPR001680 | |
| Domain | WD_REPEATS_1 | 2.12e-03 | 278 | 61 | 5 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.16e-03 | 279 | 61 | 5 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.16e-03 | 279 | 61 | 5 | PS50294 | |
| Domain | - | 4.67e-03 | 207 | 61 | 4 | 1.25.40.10 | |
| Pubmed | XPO5 UTP15 ANAPC1 MTOR CLTC GEMIN5 PDS5A PYGL PUM3 ECPAS DYNC1H1 XPOT | 2.82e-09 | 653 | 65 | 12 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | XPO5 UTP15 GGCT ANAPC1 MTOR CLTC CC2D2A GEMIN5 PDS5A PUM3 ECPAS NCAPH TOP2A DYNC1H1 XPOT | 4.31e-08 | 1425 | 65 | 15 | 30948266 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MRPS10 TRAPPC11 MAP1A UTP15 MTOR CLTC PDS5A PUM3 NCAPH TOP2A DYNC1H1 | 7.18e-08 | 704 | 65 | 11 | 29955894 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UTP15 GGCT AAMDC MTOR TECR KIF21A CLTC LRP1 GEMIN5 PYGL STK39 ECPAS NCAPH TOP2A | 1.83e-07 | 1367 | 65 | 14 | 32687490 |
| Pubmed | 2.74e-07 | 634 | 65 | 10 | 34591612 | ||
| Pubmed | MRPS10 XPO5 CORO2A MTOR TECR CLTC GEMIN5 PDS5A PUM3 ECPAS NCAPH TOP2A DYNC1H1 XPOT | 3.44e-07 | 1440 | 65 | 14 | 30833792 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UTP15 GGCT KIF21A CLTC GEMIN5 PDS5A PYGL PUM3 TANC1 NCAPH TOP2A DYNC1H1 XPOT | 1.10e-06 | 1353 | 65 | 13 | 29467282 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.21e-06 | 202 | 65 | 6 | 33005030 | |
| Pubmed | 2.45e-06 | 323 | 65 | 7 | 24797263 | ||
| Pubmed | 2.85e-06 | 638 | 65 | 9 | 33239621 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.94e-06 | 332 | 65 | 7 | 32786267 | |
| Pubmed | 3.15e-06 | 120 | 65 | 5 | 27320910 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 3.19e-06 | 647 | 65 | 9 | 26618866 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 21367918 | ||
| Pubmed | 3.61e-06 | 657 | 65 | 9 | 36180527 | ||
| Pubmed | 7.34e-06 | 66 | 65 | 4 | 36398858 | ||
| Pubmed | 9.69e-06 | 560 | 65 | 8 | 35241646 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 25961503 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 39056503 | ||
| Pubmed | 1.11e-05 | 407 | 65 | 7 | 12693553 | ||
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 1.76e-05 | 27 | 65 | 3 | 23027611 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 19147678 | ||
| Pubmed | The role of c-Src in integrin (α6β4) dependent translational control. | 2.06e-05 | 4 | 65 | 2 | 24180592 | |
| Pubmed | 3.03e-05 | 320 | 65 | 6 | 28685749 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MRPS10 XPO5 UTP15 TECR CLTC GEMIN5 PYGL NCAPH TOP2A DYNC1H1 XPOT | 3.03e-05 | 1318 | 65 | 11 | 30463901 |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 22383528 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 21454706 | ||
| Pubmed | 3.63e-05 | 1103 | 65 | 10 | 34189442 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MRPS10 XPO5 CORO2A CLTC GEMIN5 PDS5A PYGL ECPAS NCAPH DYNC1H1 | 5.12e-05 | 1149 | 65 | 10 | 35446349 |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 23640057 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 21177249 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 18602423 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 23759979 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MRPS10 GGCT AAMDC KIF21A CLTC GEMIN5 PDS5A NCAPH TOP2A DYNC1H1 XPOT | 5.77e-05 | 1415 | 65 | 11 | 28515276 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 6.20e-05 | 942 | 65 | 9 | 31073040 | |
| Pubmed | 6.38e-05 | 730 | 65 | 8 | 34857952 | ||
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 7.27e-05 | 118 | 65 | 4 | 27377895 | |
| Pubmed | 7.29e-05 | 43 | 65 | 3 | 36950384 | ||
| Pubmed | 7.42e-05 | 549 | 65 | 7 | 38280479 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 7.50e-05 | 1203 | 65 | 10 | 29180619 | |
| Pubmed | Aire's partners in the molecular control of immunological tolerance. | 8.36e-05 | 45 | 65 | 3 | 20085707 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MRPS10 AKAP9 UTP15 ALDH1L2 TECR CLTC VPS13A SENP2 TANC1 DDHD2 TOP2A | 9.48e-05 | 1496 | 65 | 11 | 32877691 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.07e-04 | 582 | 65 | 7 | 20467437 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.20e-04 | 256 | 65 | 5 | 33397691 | |
| Pubmed | 1.32e-04 | 418 | 65 | 6 | 35338135 | ||
| Pubmed | Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance. | 1.53e-04 | 10 | 65 | 2 | 26005850 | |
| Pubmed | Condensins I and II are essential for construction of bivalent chromosomes in mouse oocytes. | 1.53e-04 | 10 | 65 | 2 | 21795393 | |
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 23746204 | ||
| Pubmed | 1.68e-04 | 437 | 65 | 6 | 20562859 | ||
| Pubmed | 1.83e-04 | 150 | 65 | 4 | 32423001 | ||
| Pubmed | 1.93e-04 | 641 | 65 | 7 | 36057605 | ||
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 27782176 | ||
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 21411634 | ||
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 17911601 | ||
| Pubmed | 2.39e-04 | 64 | 65 | 3 | 22865885 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 2.52e-04 | 670 | 65 | 7 | 22990118 | |
| Pubmed | Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation. | 3.08e-04 | 14 | 65 | 2 | 20802490 | |
| Pubmed | Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. | 3.08e-04 | 14 | 65 | 2 | 28878358 | |
| Pubmed | HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3. | 3.08e-04 | 14 | 65 | 2 | 28739485 | |
| Pubmed | Characterization of vertebrate cohesin complexes and their regulation in prophase. | 3.08e-04 | 14 | 65 | 2 | 11076961 | |
| Pubmed | BICD2, dynactin, and LIS1 cooperate in regulating dynein recruitment to cellular structures. | 3.08e-04 | 14 | 65 | 2 | 22956769 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 3.38e-04 | 498 | 65 | 6 | 36634849 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 3.50e-04 | 1455 | 65 | 10 | 22863883 | |
| Pubmed | 3.53e-04 | 73 | 65 | 3 | 23464991 | ||
| Pubmed | 3.91e-04 | 183 | 65 | 4 | 23956138 | ||
| Pubmed | 3.97e-04 | 76 | 65 | 3 | 27542412 | ||
| Pubmed | Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. | 4.06e-04 | 16 | 65 | 2 | 16230076 | |
| Pubmed | 4.14e-04 | 335 | 65 | 5 | 15741177 | ||
| Pubmed | 4.20e-04 | 963 | 65 | 8 | 28671696 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 4.44e-04 | 736 | 65 | 7 | 29676528 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 4.52e-04 | 974 | 65 | 8 | 28675297 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 4.67e-04 | 344 | 65 | 5 | 36282215 | |
| Pubmed | Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A. | 4.97e-04 | 82 | 65 | 3 | 30274258 | |
| Pubmed | 4.97e-04 | 195 | 65 | 4 | 19454010 | ||
| Pubmed | Identification of novel spartin-interactors shows spartin is a multifunctional protein. | 5.76e-04 | 19 | 65 | 2 | 19765186 | |
| Pubmed | 5.89e-04 | 1014 | 65 | 8 | 32416067 | ||
| Pubmed | 6.20e-04 | 1285 | 65 | 9 | 35914814 | ||
| Pubmed | Identification of Protor as a novel Rictor-binding component of mTOR complex-2. | 6.39e-04 | 20 | 65 | 2 | 17461779 | |
| Pubmed | 6.63e-04 | 1297 | 65 | 9 | 33545068 | ||
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 6.67e-04 | 211 | 65 | 4 | 17314511 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 6.94e-04 | 571 | 65 | 6 | 37167062 | |
| Pubmed | 7.06e-04 | 21 | 65 | 2 | 26582913 | ||
| Pubmed | 7.16e-04 | 215 | 65 | 4 | 30462309 | ||
| Pubmed | 7.58e-04 | 383 | 65 | 5 | 29331416 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 7.64e-04 | 807 | 65 | 7 | 22681889 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 7.80e-04 | 220 | 65 | 4 | 35785414 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 7.93e-04 | 221 | 65 | 4 | 29991511 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 8.08e-04 | 588 | 65 | 6 | 38580884 | |
| Pubmed | 8.34e-04 | 224 | 65 | 4 | 32941674 | ||
| Pubmed | 9.11e-04 | 101 | 65 | 3 | 9872452 | ||
| Pubmed | 9.24e-04 | 24 | 65 | 2 | 17452356 | ||
| Pubmed | 9.24e-04 | 24 | 65 | 2 | 33705438 | ||
| Pubmed | 9.37e-04 | 102 | 65 | 3 | 9734811 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 9.60e-04 | 608 | 65 | 6 | 36089195 | |
| Pubmed | 9.64e-04 | 103 | 65 | 3 | 21706016 | ||
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 9.92e-04 | 104 | 65 | 3 | 36055981 | |
| Pubmed | 1.00e-03 | 25 | 65 | 2 | 11110696 | ||
| Pubmed | 1.01e-03 | 408 | 65 | 5 | 33766124 | ||
| Pubmed | 1.03e-03 | 237 | 65 | 4 | 29564676 | ||
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 1.05e-03 | 106 | 65 | 3 | 31024071 | |
| Interaction | SIRT7 interactions | XPO5 UTP15 ANAPC1 MTOR CLTC GEMIN5 PDS5A PYGL PUM3 ECPAS TOP2A DYNC1H1 XPOT | 4.92e-07 | 744 | 64 | 13 | int:SIRT7 |
| Interaction | TNFSF13B interactions | 2.12e-06 | 119 | 64 | 6 | int:TNFSF13B | |
| Interaction | GYPA interactions | 1.88e-05 | 174 | 64 | 6 | int:GYPA | |
| Interaction | P2RY6 interactions | 2.87e-05 | 385 | 64 | 8 | int:P2RY6 | |
| Interaction | LRRC31 interactions | 4.72e-05 | 205 | 64 | 6 | int:LRRC31 | |
| Interaction | HCST interactions | 4.72e-05 | 205 | 64 | 6 | int:HCST | |
| Interaction | FLT3 interactions | 6.55e-05 | 318 | 64 | 7 | int:FLT3 | |
| Interaction | FOXB1 interactions | 6.95e-05 | 135 | 64 | 5 | int:FOXB1 | |
| Interaction | MAPRE3 interactions | 8.93e-05 | 230 | 64 | 6 | int:MAPRE3 | |
| Interaction | ACP3 interactions | 9.13e-05 | 143 | 64 | 5 | int:ACP3 | |
| Interaction | GBE1 interactions | 9.49e-05 | 75 | 64 | 4 | int:GBE1 | |
| Interaction | HTR3D interactions | 9.87e-05 | 5 | 64 | 2 | int:HTR3D | |
| Interaction | EFNA4 interactions | 1.10e-04 | 239 | 64 | 6 | int:EFNA4 | |
| Interaction | CYP2J2 interactions | 1.17e-04 | 30 | 64 | 3 | int:CYP2J2 | |
| Cytoband | 2q11.2 | 1.51e-04 | 72 | 65 | 3 | 2q11.2 | |
| GeneFamily | Exportins | 1.15e-04 | 7 | 43 | 2 | 547 | |
| GeneFamily | WD repeat domain containing | 3.78e-04 | 262 | 43 | 5 | 362 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-08 | 197 | 65 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.86e-07 | 193 | 65 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.10e-07 | 195 | 65 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 195 | 65 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 195 | 65 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-07 | 197 | 65 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-07 | 197 | 65 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-07 | 197 | 65 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.33e-06 | 184 | 65 | 5 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.33e-06 | 184 | 65 | 5 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 7.33e-06 | 184 | 65 | 5 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.33e-06 | 184 | 65 | 5 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.33e-06 | 184 | 65 | 5 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 7.33e-06 | 184 | 65 | 5 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 7.33e-06 | 184 | 65 | 5 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | 3'-Distal_airway|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.48e-06 | 194 | 65 | 5 | e9ff4398e880d13894e52c0ba9cf19a7662c248b | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.72e-06 | 195 | 65 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.72e-06 | 195 | 65 | 5 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.72e-06 | 195 | 65 | 5 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 9.96e-06 | 196 | 65 | 5 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.02e-05 | 197 | 65 | 5 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-05 | 197 | 65 | 5 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-05 | 97 | 65 | 4 | a1279377bf0ee5662db8b9303f5f1fd418dee6df | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-05 | 97 | 65 | 4 | 12cbd03b33e76e5e471bbee2a9c11f27e8b21123 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-05 | 124 | 65 | 4 | d88bce8a4f023d5b617b2e8e372a94bd1248d20d | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 167 | 65 | 4 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 167 | 65 | 4 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 167 | 65 | 4 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 168 | 65 | 4 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-04 | 168 | 65 | 4 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 168 | 65 | 4 | 32e4d82efaccf336d347e4063253c3635a3ec672 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 168 | 65 | 4 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | ASK440-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.06e-04 | 168 | 65 | 4 | 127559d1a083c68cda9fce143afcc3eec168df17 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 169 | 65 | 4 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | Control-T/NK_proliferative|World / Disease group and Cell class | 1.09e-04 | 169 | 65 | 4 | fca735cbb55fce4d32dc6632a39acea1d16b87ab | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-04 | 169 | 65 | 4 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 1.19e-04 | 173 | 65 | 4 | 783b8fa08b9d8f597f251793eae164151662f1f9 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 176 | 65 | 4 | 270d7908dbd84028958d257f94941dc685e20255 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 178 | 65 | 4 | 2c581a338bf33dbd2be9abe87d0a84f97dfb546f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 178 | 65 | 4 | 5caeffb70cbb868586bd260b44ccd3751bbfa615 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic-Megakaryocytic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 178 | 65 | 4 | afc3220e2319cb38d59307db1b793a3915e1d5c4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 178 | 65 | 4 | 4ff23a0bb20c4373db14bfaad18b5fa5c7c78e76 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 180 | 65 | 4 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.51e-04 | 184 | 65 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 185 | 65 | 4 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.54e-04 | 185 | 65 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 185 | 65 | 4 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.57e-04 | 186 | 65 | 4 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 1.60e-04 | 187 | 65 | 4 | 1a2178a195d078d1963947b327c6d0d4f2f48341 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.64e-04 | 188 | 65 | 4 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.71e-04 | 190 | 65 | 4 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.71e-04 | 190 | 65 | 4 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.74e-04 | 191 | 65 | 4 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.74e-04 | 191 | 65 | 4 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.74e-04 | 191 | 65 | 4 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | PBMC-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 1.78e-04 | 192 | 65 | 4 | 4f4774b925058191673b4ba4b4d05b8b37f61795 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.78e-04 | 192 | 65 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.81e-04 | 193 | 65 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.81e-04 | 193 | 65 | 4 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-04 | 194 | 65 | 4 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.85e-04 | 194 | 65 | 4 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.85e-04 | 194 | 65 | 4 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | TCGA-Thryoid-Primary_Tumor|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.88e-04 | 195 | 65 | 4 | 7cdee2ae90edf15e4cbcf70797b8caf1f037b0ef | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.88e-04 | 195 | 65 | 4 | b61b8c931bd0ca3678486653ae1d7e9915c696c7 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-04 | 196 | 65 | 4 | a37ba02446eef5d1fab703204583f6550a8ec3e1 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-04 | 196 | 65 | 4 | d9426eba69047166ffa8179f1654e011c1020328 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.92e-04 | 196 | 65 | 4 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.92e-04 | 196 | 65 | 4 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-04 | 196 | 65 | 4 | a156840330630e518bc85633dded6f2c3ead3b30 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-04 | 196 | 65 | 4 | 7e19919eafd6ddf547dd4e8aa532a050e182c5cc | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-04 | 196 | 65 | 4 | 89ea4d2086e1c769c5a87f1471a6cd4acabcfe33 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.96e-04 | 197 | 65 | 4 | 32484fb5dde0a4525dd8028dde01ca5a4e51e4b6 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ciliated-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.96e-04 | 197 | 65 | 4 | 62e20ef825b92908d7732aa625dcff7b95ef6ca8 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.00e-04 | 198 | 65 | 4 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 2.00e-04 | 198 | 65 | 4 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 2.00e-04 | 198 | 65 | 4 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | proximal-Epithelial-Differentiating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.04e-04 | 199 | 65 | 4 | c607346f60e5997e757e5a31cab412ab3734377b | |
| ToppCell | proximal-3-Epithelial-Differentiating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.04e-04 | 199 | 65 | 4 | 12e07084fc2d5d4c418df564ccc0e132b056e549 | |
| ToppCell | proximal-Epithelial-Differentiating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.04e-04 | 199 | 65 | 4 | 96a89a2578fad9a99c52d2cf9e26e06516a96568 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-04 | 199 | 65 | 4 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-04 | 199 | 65 | 4 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 2.08e-04 | 200 | 65 | 4 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.08e-04 | 200 | 65 | 4 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 2.08e-04 | 200 | 65 | 4 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | myeloid-pro-cDC|myeloid / Lineage and Cell class | 2.08e-04 | 200 | 65 | 4 | 4aa2308eeb94e0bdff4e02eb9e45ba8837ae14bf | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.08e-04 | 200 | 65 | 4 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 2.08e-04 | 200 | 65 | 4 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| Disease | beta-citrylglutamate measurement | 9.66e-05 | 7 | 64 | 2 | EFO_0800060 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.29e-04 | 8 | 64 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 3.01e-04 | 12 | 64 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | chronic kidney disease (implicated_via_orthology) | 3.01e-04 | 12 | 64 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | Malformations of Cortical Development | 4.14e-04 | 14 | 64 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 4.14e-04 | 14 | 64 | 2 | C0431380 | |
| Disease | status epilepticus (implicated_via_orthology) | 9.47e-04 | 21 | 64 | 2 | DOID:1824 (implicated_via_orthology) | |
| Disease | myocardial infarction (is_implicated_in) | 1.32e-03 | 99 | 64 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | Left Ventricular Hypertrophy | 1.35e-03 | 25 | 64 | 2 | C0149721 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.69e-03 | 28 | 64 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | intellectual disability (is_implicated_in) | 1.94e-03 | 30 | 64 | 2 | DOID:1059 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IASLSWGQMKVKGSN | 6 | Q9H7C9 | |
| WPKNGLLDMNKGLSL | 286 | O43414 | |
| GQLDQKTAMSLLWKS | 371 | P23141 | |
| RLSKIWGQQTDGMKL | 1276 | Q99996 | |
| FKKNGLIMSSGQAWK | 121 | P51589 | |
| INWTLIMGDKKAGFS | 141 | Q3SY69 | |
| KKIGIWNSNSGLNMT | 416 | P39086 | |
| QWSAGIALMKNILGF | 206 | P50052 | |
| KNSQLKTLLAIGGWN | 86 | Q9BZP6 | |
| SGWALNMKELKLLQT | 186 | P41240 | |
| LLSIAKQLGIMTNWK | 261 | Q5TEZ5 | |
| LIGWSQGKQLLSMFT | 311 | O75185 | |
| LWSSATGKLQGKQHM | 1026 | Q149M9 | |
| LLVRWLLGMKNNQSK | 841 | Q29RF7 | |
| GMKNLKSWASVNRGA | 586 | Q15397 | |
| AGNMVIWSKGSKSQA | 96 | Q9H1A4 | |
| NSRLKNKMWYGLLGT | 886 | Q5KSL6 | |
| NKMWYGLLGTKELLQ | 891 | Q5KSL6 | |
| MQKWAGNSKAKTGIV | 216 | P78559 | |
| WAGLAKQGLSMKTLL | 761 | O75420 | |
| MLKKQSAGLVLWGAI | 1 | P26572 | |
| KLLGMQQESRLWKLG | 41 | Q5YKI7 | |
| LGKATALAIMGDKLW | 1786 | Q07954 | |
| NLSMSLWGKNKNITV | 3986 | Q5CZC0 | |
| WLTISNIGIMKGGSK | 531 | Q9UQ16 | |
| LQSQSWKMKAQGAIA | 1536 | Q5VYK3 | |
| NLKLDKMVGWLLQQS | 521 | Q9BXM7 | |
| LKNNLLGSLRMAWKS | 586 | O94830 | |
| GVVWKMNKSNLNSLD | 81 | O75223 | |
| GLGKTTLAQKLMLDW | 216 | Q9NX02 | |
| FLSLGKKAWLLMGNA | 1376 | Q9P2K1 | |
| TKLTQNGDMLDLLKW | 576 | Q8N1I0 | |
| LGNLKKLMSTGTSRW | 231 | Q92828 | |
| KMFAIATINKAGWGT | 451 | Q92819 | |
| LVNDNWKLGMNKRSL | 181 | A0A0U1RQE8 | |
| SGSGKSMAWRVLLKA | 2226 | Q14204 | |
| GMNSGSELGKLWRKL | 51 | Q96LM9 | |
| MDWKTLQALLSGVNK | 1 | O75712 | |
| LLNWRLMDTNTKGNK | 2426 | P42345 | |
| GSWNNMLKLGNKSPN | 111 | Q9HC62 | |
| VWDMLKGGQLLVSLK | 231 | Q8TED0 | |
| AKNGGLLLSTNMKWV | 31 | P82664 | |
| WGLRNMKKASSPQLL | 1251 | A0AVI2 | |
| KGAKLGNAAWAMATS | 1266 | Q9C0D5 | |
| RSWNLMKQGASGIKE | 451 | P07225 | |
| GIKKSGMATENLWLS | 106 | Q70Z44 | |
| MLKQLWSSSKGLDSL | 481 | Q8N8U2 | |
| AVWSQLAKAQLQKGM | 1106 | Q00610 | |
| KLKQSMWSLLTALSG | 646 | Q15003 | |
| TKWIKKQMSNGAFSG | 226 | Q7RTY3 | |
| MGLLSQRKWTLSGSQ | 1 | Q8N2B8 | |
| QLSLGIWKGAVALKN | 26 | Q96RL7 | |
| LKTGWMNKHLNLVPA | 81 | Q7Z392 | |
| MWDLKRFQSTGKLTG | 1476 | Q7Z4S6 | |
| MLWKGDLKGVLQTAA | 926 | Q8TEQ6 | |
| WLFTSVLKGLQMHGQ | 1071 | Q9HAV4 | |
| SLVGFTQMTIWAKGK | 271 | Q9NZ01 | |
| TGGKKLLLFERSWMN | 146 | P49754 | |
| LTLPFSWQNMGKNLK | 406 | Q6IQ21 | |
| SWQNMGKNLKGILTT | 411 | Q6IQ21 | |
| WLLGMLGAESAKLNN | 1036 | P11388 | |
| NGMGQSLIVSWSKLI | 296 | O43592 | |
| SLNMLKGPWGLSDQK | 746 | Q502W6 | |
| KDELWLVMKLLSGGS | 131 | Q9UEW8 | |
| KAWNTMVLKNIAASG | 796 | P06737 | |
| LWMKELQTQRGKHSG | 66 | Q14590 | |
| QEIARSFGKLMSKGW | 386 | Q9Y3Q0 | |
| KGVLKEWTLMLHGTQ | 581 | P16519 |